Twin Screw Melt Granulation of Simvastatin: Drug Solubility and Dissolution Rate Enhancement Using Polymer Blends
<b>Background/Objectives:</b> This study evaluates the efficacy of twin screw melt granulation (TSMG), and hot-melt extrusion (HME) techniques in enhancing the solubility and dissolution of simvastatin (SIM), a poorly water-soluble drug with low bioavailability. Additionally, the study explores the impact of binary polymer blends on the drug's miscibility, solubility, and in vitro release profile. <b>Methods:</b> SIM was processed with various polymeric combinations at a 30% <i>w</i>/<i>w</i> drug load, and a 1:1 ratio of binary polymer blends, including Soluplus<sup>®</sup> (SOP), Kollidon<sup>®</sup> K12 (K12), Kollidon<sup>®</sup> VA64 (KVA), and Kollicoat<sup>®</sup> IR (KIR). The solid dispersions were characterized using modulated differential scanning calorimetry (M-DSC), powder X-ray diffraction (PXRD), and Fourier-transform infrared spectroscopy (FTIR). Dissolution studies compared the developed formulations against a marketed product. <b>Results:</b> The SIM-SOP/KIR blend showed the highest solubility (34 µg/mL), achieving an approximately 5.5-fold enhancement over the pure drug. Dissolution studies showed that SIM-SOP/KIR formulations had significantly higher release profiles than the physical mixture (PM) and pure drug (<i>p</i> < 0.01). Additionally, their release was similar to a marketed formulation, with 100% drug release within 30 min. In contrast, the SIM-K12/KIR formulation exhibited strong miscibility, but limited solubility and slower release rates, suggesting that high miscibility does not necessarily correlate with improved solubility. <b>Conclusions:</b> This study demonstrates the effectiveness of TSMG, and HME as effective continuous manufacturing technologies for improving the therapeutic efficacy of poorly water-soluble drugs. It also emphasizes the complexity of polymer-drug interactions and the necessity of carefully selecting compatible polymers to optimize the quality and performance of pharmaceutical formulations.
Authors
- Rasha M. Elkanayati (ORCID: https://orcid.org/0009-0000-2600-6791)
- Michael A. Repka (ORCID: https://orcid.org/0000-0003-2049-4696)
- Krizia M. Karry
- Nagarjuna Narala
- Sateesh Kumar Vemula (ORCID: https://orcid.org/0000-0001-9860-0976)
- Indrajeet Karnik (ORCID: https://orcid.org/0009-0000-6450-4230)
- Prateek Uttreja (ORCID: https://orcid.org/0009-0000-2962-5387)
Institutions
- BASF (United States) (US)
- University of Mississippi (US)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2024-12-23
- DOI
- https://doi.org/10.3390/pharmaceutics16121630
- Citations
- 9
- Primary Topic
- Drug Solubulity and Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 1.87